Brett Sandercock - 08 Apr 2025 Form 4 Insider Report for RESMED INC (RMD)

Signature
Brett Sandercock, Chief Financial Officer
Issuer symbol
RMD
Transactions as of
08 Apr 2025
Transactions value $
-$215,580
Form type
4
Date filed
10 Apr 2025, 18:14
Previous filing
11 Mar 2025
Next filing
27 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$216K -1K -1.1% $215.58 89.9K 08 Apr 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan adopted February 6, 2024.